TY - JOUR
T1 - Identification and functional characterization of a novel pax8 mutation (P.his39pro) causing familial thyroid hypoplasia
AU - Iwahashi-Odano, Megumi
AU - Fujisawa, Yasuko
AU - Ogata, Tsutomu
AU - Nakashima, Shinichi
AU - Muramatsu, Mayumi
AU - Narumi, Satoshi
N1 - Funding Information:
This study was supported by JSPS KAKENHI (19K22607) to SN.
Publisher Copyright:
© 2020 by The Japanese Society for Pediatric Endocrinology.
PY - 2020/10
Y1 - 2020/10
N2 - Mutations in PAX8, the gene for a thyroid-specific transcription factor, causes congenital hypothyroidism (CH) with autosomal dominant inheritance. All previously detected PAX8 mutations except one are located in the DNA-binding paired domain. The proband, a 1-yr-old boy, was diagnosed with CH in the frame of newborn screening. He had high serum TSH level (180 mU/L) and low serum free T4 level (0.4 ng/dL). Ultrasonography revealed that the proband had thyroid hypoplasia. Importantly, he had a family history of CH, i.e., his mother also had CH and hypoplasia. Next generation sequencing-based mutation screening revealed a novel heterozygous PAX8 mutation (c.116A>C, p.His39Pro) that was transmitted to the proband from the mother. Expression experiments with HeLa cells confirmed that His39Pro-PAX8 exhibited defective transactivation of the TG promoter–luciferase reporter. In conclusion, we identified and described a novel loss-of-function PAX8 mutation in a family with thyroid hypoplasia. Patients with dominantly inherited CH and no extrathyroidal abnormalities could have PAX8 mutations.
AB - Mutations in PAX8, the gene for a thyroid-specific transcription factor, causes congenital hypothyroidism (CH) with autosomal dominant inheritance. All previously detected PAX8 mutations except one are located in the DNA-binding paired domain. The proband, a 1-yr-old boy, was diagnosed with CH in the frame of newborn screening. He had high serum TSH level (180 mU/L) and low serum free T4 level (0.4 ng/dL). Ultrasonography revealed that the proband had thyroid hypoplasia. Importantly, he had a family history of CH, i.e., his mother also had CH and hypoplasia. Next generation sequencing-based mutation screening revealed a novel heterozygous PAX8 mutation (c.116A>C, p.His39Pro) that was transmitted to the proband from the mother. Expression experiments with HeLa cells confirmed that His39Pro-PAX8 exhibited defective transactivation of the TG promoter–luciferase reporter. In conclusion, we identified and described a novel loss-of-function PAX8 mutation in a family with thyroid hypoplasia. Patients with dominantly inherited CH and no extrathyroidal abnormalities could have PAX8 mutations.
KW - Congenital hypothyroidism
KW - Genetics
KW - Mutation
KW - PAX8
UR - http://www.scopus.com/inward/record.url?scp=85092061093&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092061093&partnerID=8YFLogxK
U2 - 10.1297/cpe.29.173
DO - 10.1297/cpe.29.173
M3 - Article
AN - SCOPUS:85092061093
SN - 0918-5739
VL - 29
SP - 173
EP - 178
JO - Clinical Pediatric Endocrinology
JF - Clinical Pediatric Endocrinology
IS - 4
ER -